October 10, 2024, 09:51 AM - 8 min read
The dietary supplement market has sought to cash in on the GLP-1 demand with pills, teas, extracts and all manner of other products that claim to produce similar effects as the brand names at a much lower price.
Read more
September 27, 2024, 10:26 AM - 5 min read
The arrival of GLP-1 analogue drugs (such as Wegovy) marked a huge shift in the weight loss drug market. These drugs have been shown to lead to significant weight loss in users – as much as 15% or more of their body weight in clinical trials.
Read more
August 7, 2024, 10:58 AM - 2 min read
Originally developed as a treatment for type 2 diabetes, so-called “skinny jabs” containing the appetite-suppressant semaglutide are a relatively recent innovation.
Read more
July 6, 2024, 12:08 PM - 2 min read
Patients using diabetes and weight-loss drugs Ozempic and Wegovy might face a higher risk of developing a serious eye condition. This condition, called a stroke of the optic nerve or NAION, can lead to blindness, as per new research findings.
Read more
April 10, 2024, 09:19 PM - 2 min read
The Ozempic buzz isn't just rooted in health and medicine but plays into ideas of fat stigma and fat phobia. This can perpetuate fears of fatness and fat people, and the behaviours that harm people who live in larger bodies
Read more